Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TEMOFRAC: Ultrafractionated Radiation + Temozolomide in Inoperable GBM
NCT03310372Phase 2Completed
- Sponsor
- CHRU de Nancy - Hôpital Central
- Start
- Feb 2008
- Primary completion
- Jun 2012
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of temozolomide in glioblastoma multiforme (GBM), sponsored by CHRU de Nancy - Hôpital Central. Started Feb 2008; status: completed.
02
Drugs
temozolomide
03
Conditions
glioblastoma multiforme (GBM)
Beyond the preview
Go deeper on NCT03310372.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03310372.